FDA cleared the SYNERJET PRO (SP-1002); InPhiuse (SP-1002); WOWJET (SP-1002) from Hironic Co., Ltd. on Apr 6, 2026 under K260397, a traditional 510(k). The device falls under product code GEI, Electrosurgical, Cutting & Coagulation & Accessories, regulated at 21 CFR 878.4400 as a Class 2 device. The review panel was General, Plastic Surgery.
FDA logged the submission as received on Feb 6, 2026. The decision came 59 days later, inside the 90 FDA-day goal for a 510(k).
Hironic Co., Ltd. has one other decision in the tracker over the last 12 months: K251334 (NEW DOUBLO 2.0).
Questions & Answers
What did FDA clear under K260397?
K260397 is the FDA 510(k) for SYNERJET PRO (SP-1002); InPhiuse (SP-1002); WOWJET (SP-1002), submitted by Hironic Co., Ltd.. FDA's decision date was Apr 6, 2026, under product code GEI (Electrosurgical, Cutting & Coagulation & Accessories).
Who makes the SYNERJET PRO (SP-1002); InPhiuse (SP-1002); WOWJET (SP-1002)?
Hironic Co., Ltd., based in Yongin-Si, is the applicant of record for K260397.
How long did the K260397 review take?
FDA received the submission on Feb 6, 2026 and issued its decision on Apr 6, 2026, 59 days later.